“There were rumors from a month ago, but they proved true. I am at a loss for words at the announcement that the department will be closed down."

With the news that MSD Korea’s blockbuster antidiabetic treatment ‘Januvia Series’ will be handed over to Chong Kun Dang, the employees at MSD Korea received the crushing news that the company’s General Medicine Business Unit that used to sell Januvia will be shut down. Blinded by the unexpected blow, the employees are currently at a loss for words.

Although the company refrained from directly using the term, ‘closure of a department,’ the notice included phrases such as ‘we are deeply grateful to MSD Korea’s GM employees who have show